| 04/15/2026 11:15 PM | Evogene (1574565) Filer | Form EFFECT | |
| 04/09/2026 3:01 PM | Evogene (1574565) Issuer Ravzin Polina (2128130) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/05/2026 11:15 PM | Evogene (1574565) Filer | Form EFFECT | |
| 03/26/2026 3:26 PM | Evogene (1574565) Filer | Form POS AM | |
| 03/26/2026 3:28 PM | Evogene (1574565) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/26/2026 3:28 PM | Evogene (1574565) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/26/2026 3:30 PM | Evogene (1574565) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 03/18/2026 8:23 AM | Evogene (1574565) Issuer RECANATI LEON (919590) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:24 AM | Evogene (1574565) Issuer Percy Adrian John (1980816) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:09 AM | ELDAD YARON (1408407) Reporting Evogene (1574565) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:27 AM | Evogene (1574565) Issuer Nimrodi Nir (1602806) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for EVGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/18/2026 7:03 AM | Evogene (1574565) Issuer Falk Dan Michael (1966097) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:14 AM | Evogene (1574565) Issuer Firon Sarit (1437265) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:16 AM | Evogene (1574565) Issuer Zhidkov Ilia (2085018) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/05/2026 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/25/2026 7:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/04/2026 7:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/15/2026 3:00 PM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/30/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/20/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/19/2025 11:15 PM | Evogene (1574565) Filer | Form EFFECT | |
| 09/30/2025 6:16 AM | Evogene (1574565) Filer | Form POS AM | |
| 09/30/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/10/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/19/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/18/2025 3:01 PM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/08/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/21/2025 6:00 AM | Evogene (1574565) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |